Related Experiment Video
Updated: Feb 8, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
Hypovitaminosis D and Obesity - Coincidence or Consequence?
Fernanda Reis de Azevedo1, Bruno Caramelli2
1PhD Student.
European Endocrinology
|June 21, 2018
Summary
Vitamin D deficiency and obesity are rising. Research suggests a link, possibly involving fat accumulation, but the exact mechanism requires further study for effective treatments.
Area of Science:
- Endocrinology
- Nutritional Science
- Public Health
Background:
- Recent scientific interest in Vitamin D's roles in metabolism and cell proliferation.
- Coinciding rise in Vitamin D deficiency (hypovitaminosis D) and obesity incidence globally.
- Growing concern over the public health impact of both conditions.
Purpose of the Study:
- To investigate the association between Vitamin D levels and obesity.
- To explore potential mechanisms underlying this relationship.
- To assess the current evidence regarding a causal link.
Main Methods:
- Review of existing scientific literature and data.
- Analysis of prevalence studies on hypovitaminosis D and obesity.
- Examination of proposed biological and evolutionary hypotheses.
Main Results:
- Evidence suggests Vitamin D is involved in fat accumulation.
- The precise mechanism remains unclear, with several hypotheses proposed.
- Data are currently inconclusive regarding a definitive causal relationship.
Conclusions:
- Further research is essential to elucidate the directionality of the Vitamin D-obesity connection.
- Understanding the mechanism is key to developing therapeutic strategies.
- Potential strategies may involve Vitamin D supplementation and obesity management.
Related Concept Videos
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Timing and Consequences on Behavior
404
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective.
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
404
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
287
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
287
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
191
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
191
Egoism and Altruism
93.4K
Voluntary behavior with the intent to help other people is called prosocial behavior. Why do people help other people? Is personal benefit such as feeling good about oneself the only reason people help one another?
93.4K

